The efficacy and safety of monoclonal antibody treatments against COVID-19: A systematic review and meta-analysis of randomized clinical trials

Ifan Ali Wafa, Nando Reza Pratama, David Setyo Budi, Henry Sutanto, Alfian Nur Rosyid, Citrawati Dyah Kencono Wungu
doi: https://doi.org/10.1101/2021.06.04.21258343

Article usage

Article usage: June 2021 to November 2024

AbstractFullPdf
Jun 2021112841178
Jul 20212173857
Aug 202135479143
Sep 20218746485
Oct 20212208989
Nov 20211596068
Dec 202117610352
Jan 2022989743
Feb 2022823518
Mar 2022693332
Apr 2022622320
May 2022742923
Jun 2022552313
Jul 202250103
Aug 2022451518
Sep 2022491415
Oct 2022472213
Nov 202243918
Dec 20223149
Jan 202340712
Feb 20233888
Mar 20233533
Apr 2023301124
May 20233278
Jun 20231562
Jul 20231949
Aug 202326107
Sep 20231879
Oct 202329214
Nov 2023341115
Dec 20231957
Jan 20241147
Feb 202418512
Mar 202425812
Apr 202446713
May 20243157
Jun 20243358
Jul 20245149
Aug 202432811
Sep 202457212
Oct 202427211
Nov 20248211
Back to top
Posted June 07, 2021.
Download PDF

Supplementary Material

Data/Code
Email
The efficacy and safety of monoclonal antibody treatments against COVID-19: A systematic review and meta-analysis of randomized clinical trials
Ifan Ali Wafa, Nando Reza Pratama, David Setyo Budi, Henry Sutanto, Alfian Nur Rosyid, Citrawati Dyah Kencono Wungu
medRxiv 2021.06.04.21258343; doi: https://doi.org/10.1101/2021.06.04.21258343
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area